Molekulare Brustbildgebung

Abstract

It can be expected that molecular imaging of breast tumors will enable a simultaneous assessment of the multiple metabolic and molecular processes involved in cancer development and thus an improved detection, characterization, staging and monitoring of response to treatment will become possible.

Augmented Whole-Body Scanning via Magnifying PET

“…Parallel to the efforts from clinical PET/CT manufacturers, several groups developed organspecific PET (or PET/CT) systems that place high-resolution detectors around an organ-ofinterest to maximize the image resolution and system sensitivity [14][15][16][17][18][19][20][21]. However, these devices are incompatible with clinical utility of PET that focuses on whole-body imaging and cancer staging.…”